Business
Up 36% in a year, why this $8 billion ASX 200 stock has still a ‘strong growth forecast’
Image source: Getty Images
Looking for a quality, under-the-radar S&P/ASX 200 Index (ASX: XJO) stock with strong forecast revenue growth?
Then you may want to check out Telix Pharmaceuticals Ltd (ASX: TLX).
Shares in the diagnostic and therapeutic product developer closed on Friday trading for…
Continue Reading
-
General16 hours agoMelbourne lawyer fled Australia with $1.2m after filing for bankruptcy, court case alleges
-
Noosa News17 hours agoWounding investigation, Mooloolaba – Sunshine Coast
-
Noosa News12 hours agoMaroons name Gehamat Shibasaki for State of Origin debut against Blues, Josh Papali’i returns
-
Business13 hours agoCan the Xero share price deliver a 17% return after the US acquisition?